Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Timothy C. Wentworth (Director): Grant/Award of 135 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Timothy C. Wentworth | Grant/Award | 135 | n/a |
| Sep 3, 2026 | J. E. Davis, CEO and President | Sale | 10,000 | $2.43M |
| Aug 31, 2026 | Michael E. Prevoznik, SVP & General Counsel | Exercise/Conversion | 22,677 | $2.54M |
| Jul 29, 2026 | Mark E. Delaney, SVP & Chief Commercial Officer | Sale | 1,600 | $376.3K |
| Jul 27, 2026 | Karthik Kuppusamy, SVP, Clinical Solutions | Small Acquisition | 37 | $7.7K |
| Jul 27, 2026 | Robert B. Carter | Small Acquisition | 11 | $2.3K |
| Jul 27, 2026 | Vicky B. Gregg | Grant/Award | 72 | $14.9K |
| Jul 27, 2026 | Patrick Plewman, SVP for Diagnostic Services | Small Acquisition | 46 | $9.5K |
| Jul 27, 2026 | Timothy L. Main | Small Acquisition | 21 | $4.3K |
| Jul 27, 2026 | Sam Samad, Executive Vice President & CFO | Grant/Award | 102 | $21.1K |